Product Information
TOBRAMYCIN 80 MG/2 ML VIAL is a generic product labeled by Hospira Inc., priced at $0.7395 per ML under NDC 00409357801. Its NADAC has been published 309 times since Nov 28, 2013.
FDA first approved this application on Apr 30, 1991. Its Orange Book therapeutic-equivalence code is AP.
The Low Outlier badge above means this manufacturer's average price in the TOBRAMYCIN market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/mL
Manufacturer
Hospira Inc.NDC
00409357801
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
8/19/2026
Active Ingredients
TOBRAMYCIN SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA063111FDA Approved
4/30/1991
TE Code
AP
On Market Since
5/5/2005
Pharmacological Classes
Price Statistics
The NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has been published 309 times since Nov 28, 2013, and over the history we have for it it has declined 42.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7395 per ML |
|---|---|
| All-time high | $1.4932 (Jan 15, 2014) |
| All-time low | $0.5997 (Mar 18, 2026) |
| 52-week high | $0.8372 |
| 52-week low | $0.5997 |
| Median price | $0.8443 |
| Average price | $0.8464 |
| Largest weekly change | +101.1% (Aug 20, 2014) |
| Weeks tracked | 309 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the TOBRAMYCIN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOBRAMYCIN 80 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN 80 MG/2 ML VIAL, manufactured by Hospira Inc., is $0.7395 per ML (NDC 00409357801), effective Aug 19, 2026.
How has the price of TOBRAMYCIN 80 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has declined 42.1%. It has been tracked across 309 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TOBRAMYCIN 80 MG/2 ML VIAL?
Since Nov 28, 2013, the NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has ranged from a low of $0.5997 (Mar 18, 2026) to a high of $1.4932 (Jan 15, 2014), with a median of $0.8443 per ML.
Are there cheaper alternatives to TOBRAMYCIN 80 MG/2 ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of TOBRAMYCIN 80 MG/2 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TOBRAMYCIN 80 MG/2 ML VIAL?
TOBRAMYCIN 80 MG/2 ML VIAL (NDC 00409357801) is labeled by Hospira Inc., and CMS classifies it as a generic product.